Parents Seek Supreme Court Intervention for No-Fault Compensation in Vaccine Deaths
Quick Revision
Two sets of parents are seeking "no-fault compensation" from the government for alleged Covid-19 vaccine-related deaths.
Rachna and Naveen Chhabra's daughter, Riya, died on August 10, 2021, after receiving the Covishield vaccine.
Venkatrao's daughter, Karunya, died on July 26, 2021, after receiving the Covishield vaccine.
Both daughters were young adults (20 and 18 years old) and died within weeks of their first vaccine dose.
The parents argue that the government should compensate victims without requiring proof of negligence.
They cite international precedents like the UK's Vaccine Damage Payment Act 1979.
The Union government stated that vaccine-related deaths are rare and a causal link is difficult to establish.
The AEFI (Adverse Events Following Immunisation) committee investigates vaccine adverse events.
Key Dates
Key Numbers
Visual Insights
COVID-19 वैक्सीन मुआवजा: सुप्रीम कोर्ट के हस्तक्षेप की दिशा में घटनाक्रम
यह टाइमलाइन COVID-19 टीकाकरण के बाद प्रतिकूल घटनाओं (AEFI) से संबंधित मुआवजे की मांग और सुप्रीम कोर्ट के महत्वपूर्ण निर्णयों को दर्शाती है, जो वर्तमान याचिका का आधार बने हैं।
COVID-19 महामारी के दौरान बड़े पैमाने पर टीकाकरण अभियान चलाया गया, जिससे कुछ व्यक्तियों में गंभीर प्रतिकूल घटनाएँ (AEFI) देखी गईं। इन घटनाओं के बाद, पीड़ितों के परिवारों ने मुआवजे की मांग की, लेकिन पारंपरिक टॉर्ट कानून के तहत लापरवाही साबित करना मुश्किल था। सुप्रीम कोर्ट ने पहले COVID-19 मौतों के लिए अनुग्रह राशि का आदेश दिया था और AEFI डेटा पारदर्शिता पर जोर दिया था। वर्तमान याचिका 'नो-फॉल्ट' मुआवजे की मांग करती है, जो राज्य की कल्याणकारी भूमिका और अनुच्छेद 21 के तहत स्वास्थ्य के अधिकार पर आधारित है।
- 2021सुप्रीम कोर्ट ने गौरव कुमार बंसल बनाम भारत संघ मामले में COVID-19 से हुई मौतों के लिए आपदा प्रबंधन कानून, 2005 के तहत ₹50,000 की अनुग्रह राशि देने का निर्देश दिया। यह एक तरह का 'नो-फॉल्ट' मुआवजा था।
- 2021करुणा और रितिका श्री ओमत्री की कथित तौर पर कोविशील्ड वैक्सीन लेने के बाद मृत्यु हो गई, जिसके बाद उनके माता-पिता ने सुप्रीम कोर्ट में याचिका दायर की।
- May 2022जैकब पुलियेल बनाम भारत संघ मामले में सुप्रीम कोर्ट ने AEFI डेटा को सार्वजनिक करने का निर्देश दिया, जिससे पारदर्शिता बढ़ी।
- Nov 2024BIT मेसरा मामले में सुप्रीम कोर्ट ने एक छात्र की मौत पर कॉलेज को ₹20 लाख का मुआवजा देने के झारखंड हाई कोर्ट के निर्देश को बरकरार रखा, जो संस्थानों की जवाबदेही पर जोर देता है।
- March 2026सुप्रीम कोर्ट ने केंद्र सरकार को COVID-19 टीकाकरण के गंभीर प्रतिकूल प्रभावों से प्रभावित लोगों के लिए 'नो-फॉल्ट' मुआवजा नीति बनाने का निर्देश दिया। यह फैसला जी. वेणुगोपालन और रचना गांगू जैसे माता-पिता की याचिकाओं पर आया है।
Mains & Interview Focus
Don't miss it!
The demand for no-fault compensation in vaccine-related deaths presents a critical policy dilemma for the Indian state, balancing public health imperatives with individual rights. While mass vaccination campaigns are indispensable for controlling epidemics, the state's responsibility extends to mitigating unforeseen adverse outcomes. The current legal framework, heavily reliant on proving negligence, places an undue burden on victims and risks eroding public trust in public health initiatives. This situation necessitates a re-evaluation of India's approach to vaccine injury compensation.
India's current stance contrasts sharply with several developed nations that have robust frameworks. Countries like the United Kingdom, through its Vaccine Damage Payment Act 1979, and the United States, with its National Vaccine Injury Compensation Program (NVICP) established in 1986, provide clear administrative mechanisms for compensation. These systems acknowledge the societal benefit of vaccination and the rare but real risk of adverse events, offering a streamlined process without requiring proof of fault from manufacturers or the government. Such proactive programs are crucial for maintaining high vaccination rates and public confidence, especially during widespread health crises.
The Union government's counter-affidavit, emphasizing the rarity of vaccine-related deaths and the difficulty in establishing a causal link, reflects a defensive posture that may be legally sound but ethically problematic. While scientific rigor in causality assessment is essential, a purely adversarial approach ignores the broader ethical dimension of public health policy. The existing Adverse Events Following Immunisation (AEFI) committee's role is primarily surveillance and causality assessment, not compensation disbursement. A dedicated, transparent, and expeditious compensation mechanism is conspicuously absent, leaving affected families in a legal quagmire.
Implementing a no-fault compensation scheme would require significant legislative action or a clear policy directive from the executive. This could involve establishing a dedicated fund, perhaps through a small levy on vaccine sales or direct government allocation, similar to how the Motor Vehicles Act provides for no-fault accident compensation. Such a fund would not only provide timely and dignified relief to affected families but also insulate vaccine manufacturers from protracted litigation, thereby encouraging continued investment in vaccine research and supply. The Supreme Court's intervention, therefore, could be a pivotal moment, compelling the executive to formulate a comprehensive policy that aligns India with global best practices in vaccine governance and reinforces the state's commitment to citizen welfare. This proactive step would strengthen the social contract between the state and its citizens in matters of public health.
Exam Angles
GS Paper II: Government policies and interventions for development in various sectors and issues arising out of their design and implementation.
GS Paper II: Mechanisms, laws, institutions and Bodies constituted for the protection and betterment of vulnerable sections.
GS Paper III: Science and Technology – Developments and their applications and effects in everyday life; Health issues.
GS Paper IV: Ethics in public administration, accountability, and ethical governance.
View Detailed Summary
Summary
Some parents are asking the Supreme Court to make the government pay money to families whose loved ones died after getting Covid-19 vaccines, even if no one was at fault. They believe that since the government promoted the vaccines for public health, it should help those who suffered rare but serious side effects, just like some other countries do.
Two parents, whose daughters allegedly died due to adverse effects of Covid-19 vaccination, have approached the Supreme Court of India, seeking the establishment of a 'no-fault compensation' policy for vaccine-related deaths and injuries. The petitioners argue that the Indian government should provide compensation to victims without requiring them to prove negligence on the part of vaccine manufacturers or administrators, a system prevalent in several developed nations. This legal challenge underscores the critical absence of a clear and comprehensive framework in India for compensating individuals who suffer adverse events following immunization (AEFI).
The parents' plea highlights a significant gap in India's public health policy, where victims currently face a cumbersome process of proving negligence, often through lengthy legal battles, to secure any form of recompense. They contend that a 'no-fault' system would streamline the compensation process, ensuring timely support for affected families and bolstering public trust in vaccination programs. The case raises fundamental questions about the government's responsibility in public health initiatives, particularly concerning the support mechanisms for citizens who experience severe adverse reactions to state-promoted health interventions.
This intervention by the Supreme Court is crucial for shaping future public health strategies and victim support systems in India. It holds significant relevance for the UPSC Civil Services Examination, particularly under GS Paper II (Polity & Governance – Government policies and interventions for development in various sectors and issues arising out of their design and implementation; Mechanisms, laws, institutions and Bodies constituted for the protection and betterment of these vulnerable sections) and GS Paper III (Science & Technology – Developments and their applications and effects in everyday life; Health issues).
Background
Latest Developments
Frequently Asked Questions
1. What is 'no-fault compensation' and how is it different from the current legal recourse available in India for vaccine-related injuries?
No-fault compensation is a system where victims of adverse events, like vaccine injuries, receive compensation without needing to prove negligence by the manufacturer or administrator.
- •No-Fault: Focuses on the injury itself, not who is at fault. Compensation is provided if a causal link to the vaccine is established, regardless of negligence.
- •Current Indian System: Victims must prove negligence (e.g., faulty vaccine, improper administration) under Tort Law or the Consumer Protection Act, which is a lengthy and complex process.
Exam Tip
Remember the core distinction: 'no-fault' means no need to prove negligence, while current Indian law *requires* proving negligence. This is a common conceptual trap.
2. What is the role of the National AEFI Committee in India, and does it currently provide compensation for vaccine-related adverse events?
The National AEFI Committee monitors and investigates serious or unexpected health problems following vaccination.
- •Its primary function is surveillance and analysis of adverse events following immunization (AEFI).
- •It *does not* directly provide compensation to victims. Its role is limited to monitoring and analyzing, not financial redressal.
Exam Tip
UPSC might try to confuse you by implying the AEFI committee *also* handles compensation. Remember its role is strictly monitoring and analysis, not compensation.
3. Why is 'no-fault compensation' being advocated now, and what are its advantages over the traditional tort law approach in vaccine injury cases?
The current plea highlights the cumbersome process of proving negligence under existing laws, which is difficult for victims, especially with complex medical evidence.
- •Ease for Victims: No-fault systems ease the burden on victims by removing the need to prove negligence, making compensation quicker and less stressful.
- •Encourages Vaccination: It can maintain public trust in vaccination programs by assuring that genuine adverse events will be addressed without lengthy legal battles.
- •Avoids Blame Game: Shifts the focus from blaming manufacturers/administrators to supporting the injured, which is crucial for public health initiatives.
Exam Tip
For Mains, when asked to 'critically examine' or 'discuss the merits', remember to highlight both the victim's plight and the public health benefits of such a system.
4. How does India's approach to vaccine injury compensation compare with the 'no-fault' systems in developed nations like the UK?
India currently lacks a specific 'no-fault' compensation framework, relying on general tort law or consumer protection acts where negligence must be proven.
- •India: Victims must prove negligence, leading to a complex and often protracted legal battle. There's no specific, streamlined mechanism for vaccine AEFI compensation.
- •Developed Nations (e.g., UK): Countries like the UK have specific legislation (e.g., Vaccine Damage Payment Act 1979) that provides compensation for vaccine-related injuries without requiring proof of negligence, focusing on the link between vaccine and injury.
Exam Tip
This comparison is crucial for Mains answers on public health policy. Mentioning the UK's 1979 Act shows depth of knowledge.
5. What are the potential challenges for the Indian government if the Supreme Court mandates a 'no-fault compensation' policy for vaccine-related adverse events?
Mandating such a policy could pose significant financial and administrative challenges for the government.
- •Financial Burden: Establishing and funding a comprehensive compensation scheme for a large population could be a massive financial undertaking.
- •Defining Causality: Even without proving negligence, establishing a clear causal link between a vaccine and an adverse event can be medically complex and lead to disputes.
- •Precedent Setting: It could set a precedent for other public health interventions or even medical treatments, potentially opening doors for similar compensation demands.
- •Public Trust vs. Liability: Balancing the need to maintain public trust in vaccines with the government's potential liability for unforeseen adverse events.
Exam Tip
When discussing government challenges, always think about financial, administrative, legal, and policy implications.
6. What broader implications does this Supreme Court plea have for public health policy and future vaccination drives in India?
This plea highlights a significant gap in India's public health policy regarding AEFI compensation and could lead to a more robust framework.
- •Policy Review: It could prompt the government to review and potentially formulate a dedicated, comprehensive policy for vaccine injury compensation.
- •Enhanced Trust: A clear compensation mechanism could enhance public trust in future vaccination drives, crucial for managing pandemics or routine immunizations.
- •Accountability: It pushes for greater accountability from both the government (for policy framework) and vaccine manufacturers (for product safety).
- •Legal Precedent: A favorable ruling could set a significant legal precedent, influencing how adverse events from other public health interventions are handled.
Exam Tip
For Mains, connect specific news items to broader policy implications and governance challenges. This shows a holistic understanding.
Practice Questions (MCQs)
1. Consider the following statements regarding 'no-fault compensation' in the context of vaccine-related adverse events: 1. It requires victims to prove negligence on the part of vaccine manufacturers or administrators to receive compensation. 2. Such policies are prevalent in several developed nations to provide timely support to affected individuals. 3. In India, the Consumer Protection Act, 2019, explicitly provides for 'no-fault compensation' for vaccine injuries. Which of the statements given above is/are correct?
- A.1 और 2
- B.केवल 2
- C.2 और 3
- D.1, 2 और 3
Show Answer
Answer: B
Statement 1 is INCORRECT: 'No-fault compensation' specifically means that victims do NOT need to prove negligence to receive compensation. The core idea is to provide compensation regardless of fault. Statement 2 is CORRECT: Many developed nations, such as the United States and the United Kingdom, have 'no-fault' vaccine injury compensation programs. These programs aim to provide quick and fair compensation to individuals who suffer adverse effects from vaccines, thereby maintaining public trust in immunization programs. Statement 3 is INCORRECT: The Consumer Protection Act, 2019, primarily deals with consumer disputes and requires proof of deficiency in service or goods. It does not explicitly provide for 'no-fault compensation' for vaccine injuries. Victims typically have to prove negligence or defect under this act or tort law.
2. Which of the following bodies in India is primarily responsible for the surveillance and investigation of Adverse Events Following Immunization (AEFI)?
- A.भारतीय चिकित्सा अनुसंधान परिषद (ICMR)
- B.राष्ट्रीय रोग नियंत्रण केंद्र (NCDC)
- C.राष्ट्रीय टीकाकरण तकनीकी सलाहकार समूह (NTAGI)
- D.राष्ट्रीय AEFI समिति (National AEFI Committee)
Show Answer
Answer: D
The National AEFI Committee (National Adverse Events Following Immunization Committee) is the primary body in India responsible for the surveillance, investigation, and causality assessment of adverse events that occur following immunization. While ICMR conducts research, NCDC focuses on disease control, and NTAGI provides technical advice on immunization policy, the specific mandate for AEFI surveillance and investigation lies with the National AEFI Committee. This committee plays a crucial role in ensuring vaccine safety and maintaining public confidence in immunization programs.
Source Articles
‘Is our son’s life worth so little?’: Family after Supreme Court order in BIT Mesra student’s death | India News - The Indian Express
Supreme Court’s landmark "no-fault" order: Why families of two young women who died after Covishield just won a 3-year legal battle
Supreme Court’s Euthanasia judgment shows dignity cannot be measured solely in heartbeats | The Indian Express
Parental income can’t be sole factor to decide creamy layer: Supreme Court | Legal News - The Indian Express
‘Process must be humane’: In a first, Supreme Court allows passive euthanasia for man in 13-year vegetative state
About the Author
Ritu SinghGovernance & Constitutional Affairs Analyst
Ritu Singh writes about Polity & Governance at GKSolver, breaking down complex developments into clear, exam-relevant analysis.
View all articles →